Regulatory Focus Pregistry specializes in regulatory requirements for drug and vaccine safety during pregnancy, indicating a potential opportunity to offer expanded compliance services, post-market surveillance, and regulatory consulting to pharma manufacturers seeking to optimize pregnancy safety data.

Acquisition Momentum As part of CorEvitas, Pregistry recently integrated into a broader pregnancy safety and observational research platform, suggesting cross-sell potential for existing CorEvitas clients and leverage of combined data capabilities to win new contracts in pregnancy registries.

Leadership Experience With a Chief Medical Officer appointed and 20 years of experience in patient registries, there is an opportunity to pitch high-level scientific collaborations, study design services, and advisory engagements to pharmaceutical teams prioritizing pregnancy safety data generation.

Growing Footprint Pregistry operates with a mid-sized team and has recognized industry awards, indicating credibility and room to scale services such as observational study execution, data curation, and real-world evidence generation targeting regulatory submissions.

Technology Stack Current tools include WordPress, analytics, and data-focused platforms, suggesting pathways to enhance data collection, analytics dashboards, and patient registry integrations for pharma sponsors seeking robust safety data during pregnancy.